Download Free Sample Report

The global Breathing Machines Market was valued at US$ 7.3 billion in 2023 and is predicted to reach US$ 12.5 billion by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period (2023-2032).

This report studies the Breathing Machines market, covering market size for segment by type (Asthma Nebulizers, PAP Machines, etc.), by application (Hospitals & Clinics, Home Healthcare, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Resmed, Philips Healthcare, Medtronic, BD, GE Healthcare, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for Breathing Machines from 2018-2023, and provides extensive market forecasts from 2024-2032 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Breathing Machines market.

Leading Players of Breathing Machines including:

• Resmed
• Philips Healthcare
• Medtronic
• BD
• GE Healthcare
• Teijin Pharma
• Drager Medical
• Fisher & Paykel
• Invacare
• PARI
• Mindray
• MEKICS
• Yuwell
• ORMON
• Air Liquide
• Weinmann
• Maquet

• Asthma Nebulizers
• PAP Machines
• Oxygen Concentrator
• Ventilators

• Hospitals & Clinics
• Home Healthcare

• Direct Channel
• Distribution Channel

• North America (United States and Canada)
• Europe (Germany, UK, France, Italy, Spain, and Russia, etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia, etc.)
• South America (Brazil, Mexico, and Argentina, etc.)
• Middle East & Africa (Turkey, UAE, Saudi Arabia, and South Africa, etc.)